Nat Rev Drug Discov. 2002 Sep;1(9):683-95.

Clinical proteomics: translating benchside promise into bedside reality.

Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA.

Source

FDA-NCI Clinical Proteomics Program, Division of Therapeutic Proteins, Center for Biologic Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA. petricoin@cber.fda.gov

Abstract

The ultimate goal of proteomics is to characterize the information flow through protein networks. This information can be a cause, or a consequence, of disease processes. Clinical proteomics is an exciting new subdiscipline of proteomics that involves the application of proteomic technologies at the bedside, and cancer, in particular, is a model disease for studying such applications. Here, we describe proteomic technologies that are being developed to detect cancer earlier, to discover the next generation of targets and imaging biomarkers, and finally to tailor the therapy to the patient.

PMID:: 12209149; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Proteome

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Review Clinical applications of proteomics. [J Nutr. 2003]
Review Clinical applications of proteomics.
Petricoin EF, Liotta LA. J Nutr. 2003 Jul; 133(7 Suppl):2476S-2484S.
Review Clinical proteomics for cancer biomarker discovery and therapeutic targeting. [Technol Cancer Res Treat. 2002]
Review Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
Krieg RC, Paweletz CP, Liotta LA, Petricoin EF 3rd. Technol Cancer Res Treat. 2002 Aug; 1(4):263-72.
Review Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. [J Proteome Res. 2004]
Review Clinical proteomics: revolutionizing disease detection and patient tailoring therapy.
Petricoin E, Wulfkuhle J, Espina V, Liotta LA. J Proteome Res. 2004 Mar-Apr; 3(2):209-17.
Review Application of proteomic technologies to tumor analysis. [Pharmacogenomics. 2004]
Review Application of proteomic technologies to tumor analysis.
Misek DE, Imafuku Y, Hanash SM. Pharmacogenomics. 2004 Dec; 5(8):1129-37.
Review Proteomic approaches in cancer risk and response assessment. [Trends Mol Med. 2004]
Review Proteomic approaches in cancer risk and response assessment.
Petricoin EF, Liotta LA. Trends Mol Med. 2004 Feb; 10(2):59-64.

See reviews... See all...

Cited by 28 PubMed Central articles

A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma. [PLoS One. 2012]
A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma.
Lin Q, Peng Q, Yao F, Pan XF, Xiong LW, Wang Y, Geng JF, Feng JX, Han BH, Bao GL, et al. PLoS One. 2012; 7(3):e34457. Epub 2012 Mar 26.
Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma. [PLoS One. 2011]
Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma.
Peng XC, Gong FM, Zhao YW, Zhou LX, Xie YW, Liao HL, Lin HJ, Li ZY, Tang MH, Tong AP. PLoS One. 2011; 6(11):e27309. Epub 2011 Nov 8.
Identification of direct target engagement biomarkers for kinase-targeted therapeutics. [PLoS One. 2011]
Identification of direct target engagement biomarkers for kinase-targeted therapeutics.
Paweletz CP, Andersen JN, Pollock R, Nagashima K, Hayashi ML, Yu SU, Guo H, Bobkova EV, Xu Z, Northrup A, et al. PLoS One. 2011; 6(10):e26459. Epub 2011 Oct 24.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Clinical proteomics: translating benchside promise into bedside reality.
Clinical proteomics: translating benchside promise into bedside reality.
Nat Rev Drug Discov. 2002 Sep ;1(9):683-95.

PubMed
Computational prediction of eukaryotic protein-coding genes.
Computational prediction of eukaryotic protein-coding genes.
Nat Rev Genet. 2002 Sep ;3(9):698-709.

PubMed
IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.
IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.
J Allergy Clin Immunol. 2002 Sep ;110(3):435-42.

PubMed
Theoretical perspectives of postpartum depression and their treatment implicatio...
Theoretical perspectives of postpartum depression and their treatment implications.
MCN Am J Matern Child Nurs. 2002 Sep-Oct ;27(5):282-7.

PubMed
Bayesian network approach to cell signaling pathway modeling.
Bayesian network approach to cell signaling pathway modeling.
Sci STKE. 2002 Sep 3 ;2002(148):pe38.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: